Batten
Batten Disease is a rare, fatal, autosomal recessive neurodegenerative disorder that begins in childhood. It is the most common form of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs). The disease is named after the British pediatrician Frederick Batten, who first described it in 1903. Batten Disease primarily affects the nervous system, leading to vision loss, cognitive decline, seizures, and progressive motor dysfunction.
Causes[edit | edit source]
Batten Disease is caused by mutations in genes that are responsible for the production of proteins involved in cell waste disposal. The body's failure to eliminate waste products leads to the abnormal accumulation of substances called lipofuscins in the body's tissues. These accumulations are toxic to cells, particularly the neurons, leading to the symptoms associated with the disease. There are several forms of Batten Disease, each associated with mutations in different genes. The most common forms include mutations in the CLN3, CLN1, CLN2, CLN6, CLN7, and CLN8 genes.
Symptoms[edit | edit source]
The symptoms of Batten Disease vary depending on the specific type but generally include:
- Vision loss
- Seizures
- Personality and behavior changes
- Cognitive decline
- Motor skills deterioration, including problems with coordination and balance
- Eventually, individuals may lose the ability to walk, talk, and communicate
Diagnosis[edit | edit source]
Diagnosis of Batten Disease involves a combination of genetic testing, which can identify mutations in specific genes associated with the disease, and diagnostic tests such as electroencephalogram (EEG) for seizure monitoring, magnetic resonance imaging (MRI) to observe brain structure and function, and skin or tissue biopsy to detect the characteristic accumulation of lipofuscins.
Treatment[edit | edit source]
There is no cure for Batten Disease, and treatment focuses on managing symptoms and providing supportive care. This may include:
- Medications to control seizures
- Physical therapy to help maintain mobility
- Occupational therapy to assist with daily activities
- Speech therapy to support communication abilities
- Nutritional support to ensure proper diet and feeding
Prognosis[edit | edit source]
The prognosis for individuals with Batten Disease is generally poor, with progression of the disease leading to increasing disability and eventually death. The life expectancy varies depending on the type of Batten Disease but is significantly shortened.
Research[edit | edit source]
Research into Batten Disease is ongoing, with efforts focused on understanding the genetic causes of the disease, developing gene therapy treatments, and finding ways to prevent the accumulation of toxic substances in cells. Clinical trials for potential treatments are also underway, offering hope for future advancements in the management of the disease.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD